Serendipity in anticancer drug discovery

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

832

HTML

13973

Figures (1-2)

230

Tables (1-5)

371

Sum=15406

Jan 10, 2012 (publication date) through Nov 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observation

World J Clin Oncol. Jan 10, 2012; 3(1): 1-6
Published online Jan 10, 2012. doi: 10.5306/wjco.v3.i1.1

Full Size Figure Download Figure

Figure 1 The distribution of the serendipity types (laboratory-based and clinical) and their chemical derivatives in clinical use (100% = 1437).

Citation: Hargrave-Thomas E, Yu B, Reynisson J. Serendipity in anticancer drug discovery. World J Clin Oncol 2012; 3(1): 1-6
URL: https://www.wjgnet.com/2218-4333/full/v3/i1/1.htm
DOI: https://dx.doi.org/10.5306/wjco.v3.i1.1